Heightened guidance at the federal, state and academic medical center level is increasing the complexity of industry-HCP interactions.  Pharmaceutical, medical device and biotech companies must understand how to establish and maintain an effective KOL program while ensuring compliance with evolving guidance.  Now in its 7^th year, CBI’s annual forum has convened over 650 industry leaders to network and develop strategies for optimizing thought leader collaboration across an organization.  Explore challenges including increased barriers to physician access, appropriate determination of FMV, implementation of an OL management system – and solutions for overcoming them.   

Conference Highlights Include:

• Comprehensive coverage of guidance around industry-HCP interactions

• Best practices companies are implementing to ensure compliance

• Focus on internal collaboration to execute global KOL strategy and a centralized management model

• Case studies from Genzyme, Novo Nordisk, Baxter Healthcare and Purdue Pharma L.P.

Hear what some of our previous attendees had to say:

“The conference provides valuable and timely insights into current best practices in the industry.  I really enjoyed the ability to talk one-on-one with other attendees and the Q&A with the speakers – excellent job!” 
– Joe Martinez, Medical Development, Senior Managed Care Liaison, Amylin Pharmaceuticals

“The conference provided a broad cross-section of views and information regarding KOL management and interaction with industry and the impact of the changing regulatory environment.  A very helpful primer for those entering or new to industry as well as providing new and updated information relevant to more experienced industry professionals.” 
– Alan Rosenthal, PharmD, Clinical Scientist, Canyon Pharmaceuticals

“Excellent opportunity to network with peers and share best practices.  Challenged one to think strategically about how to respond to shifting standards”
– Tony Magnetti, Vice President Professional Affairs, Sepracor

 “The panel discussions and informal interactions really provided a forum for sharing experiences, lessons learned and key issues.  Great sharing of information and best practices”
– Tanya Hill, Associate Director Marketing, Novo Nordisk

“Conference provided concrete takeaways both around KOL management and considerations for compliance—Very frank and open discussion for lessons learned”
– Andreas Tsukada, Associate Director Sales Operations, UCB

Sponsors/Exhibitors:

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.